News from around the world of Psychedelics.
Psychedelics sciences firm Eleusis plans to go public through a deal with SPAC Spike Acquisition Corp. II (SPKB) in a deal that give the combined company an enterprise value of $446M
Continue reading
It wasn’t that long ago when psychedelics emerged as a potentially better natural plant-based medicine for treating such things as treatment-resistant depression (TRD), into what is now a billion-dollar juggernaut of an industry. Then an even curiouser thing happened. Around 2015, organizers of more and more conferences about cannabis—and some that were not about cannabis […]
Continue reading
British psychedelics company Eleusis will go public via a merger with Silver Spike Acquisition Corp. II (“S…
Continue reading
It’s no secret that psychedelics are on the comeback trail, with a record number of trials and total investment in the hundreds of millions of dollars in
Continue readingAs the psychedelics industry is set to have another record-breaking year, we take a look at the milestones of 2021 and what we can expect in the coming year.
Continue reading
Seattle and Detroit approved this fall measures to protect consumers of “entheogenic” plants and fungi. These policies form part of a larger trend, which began […]
Continue reading
Rep. Brady Brammer acknowledges he’s not the type to run legislation on psychedelics.
Continue reading
Numinus Wellness recently announced important milestones in its clinical trial of MDMA-assisted therapy to treat individuals suffering from PTSD.
Continue reading
A wave of psychedelics legislation continues to sweep across the country.
Recently, lawmakers in Virginia and Kansas
Continue reading
Research in 60 Seconds: How Taking Psychedelics Can Be Therapeutic | Read more about UCF Arts & Culture, Colleges & Campus, Medicine, Research, Orlando and Central Florida news.
Continue reading